Rx · Prescription onlyDissolved under the tongue
Sermorelin Troches
Sleep, recovery, no needle.
Your plan
How many troches per month?
You'll receive 30 troches per month. $279 billed monthly. Cancel anytime.
- Medication, clinician care and dose adjustments, all in one price.
- ~30-day supply. Your clinician sets your exact dose, so yours may vary; your refill arrives as you finish the last one.
A licensed clinician on our care team reviews every request and prescribes only when it's clinically appropriate.
FDA status: Compounded medication, not FDA-approved.
What it's for
Who it's for
Adults who want sermorelin and will not inject.
How it's different
A troche that dissolves under the tongue. Much less is absorbed this way than by injection.
How it works
After age 30, growth hormone levels decline steadily each decade, affecting everything from metabolism and muscle tone to recovery and sleep quality. Unlike synthetic HGH, which overrides the system, sermorelin works with the body: it signals the brain to release its own growth hormone in a natural, pulsed rhythm, to support lean muscle, energy and metabolism.
How to use it and what arrives
30 troches · lasts 1 month
Your clinician sets your dose: 500–1000 mcg · same price at every dose
- How
- Dissolved under the tongue
- How often
- Once a day
- When
- At bedtime
Good to know
Let it dissolve fully. Chewed or swallowed, it is digested like any protein and does nothing.
What the research shows
A GHRH analogue made of the first 29 amino acids of the natural hormone. FDA approved it in 1997 for children with growth failure from idiopathic growth hormone deficiency; the maker discontinued it in 2008. Adult evidence is limited to small trials of hormone levels.
FDA history
approved 1997, discontinued 2008
FDA approved GEREF (sermorelin acetate) vials on September 26, 1997, for treating idiopathic growth hormone deficiency in children with growth failure. The maker, EMD Serono, discontinued it in 2008. In 2013 FDA determined it was not withdrawn for reasons of safety or effectiveness.
FDA, Federal Register determination on GEREF (sermorelin acetate), 2013Adult use
editorial, no trial data
Walker's 2006 paper is an editorial proposing sermorelin as an alternative to recombinant growth hormone in aging. It presents no trial data of its own, and says the society would supply sermorelin to practitioners to study under protocol.
Walker, Clin Interv Aging 2006Adult trials
10 to 19 older adults
Corpas (1992, 10 older men), Vittone (1997, 11 men) and Khorram (1997, 19 men and women, using a close analogue) measured growth hormone and IGF-I over 2 to 16 weeks of treatment. None measured a clinical outcome.
Corpas et al., J Clin Endocrinol Metab 1992; Vittone et al., Metabolism 1997; Khorram et al., J Clin Endocrinol Metab 1997
No approved sermorelin product is marketed: the FDA-approved GEREF is on the discontinued list. Sermorelin used today is compounded, and adult use is off-label. The injection and the sublingual troche are different products. No human trial of the troche was found.
What this does not say
- The adult trials lasted 2 to 16 weeks, and no long-term outcome trial in adults was found.
- Growth hormone-releasing drugs raise IGF-I, and the effects of sustained elevation are not established.
- Compounded product quality and dose accuracy are not verified. No human study of the sublingual troche was found.
Sources
- Review of sermorelin as a GHRH analog for adult-onset growth hormone insufficiency: stimulates the body's own growth hormone in a physiological pattern. Clinical Interventions in Aging, 2006 (Walker RF)
- Growth hormone secretion declines progressively with age in adults, with effects on body composition, muscle and sleep. Endocrine Reviews, 1993 (Corpas E, Harman SM, Blackman MR)
- Growth hormone-releasing hormone improved cognition in healthy older adults in a randomized trial. Neurobiology of Aging, 2006 (Vitiello MV et al.)
- Sermorelin's mechanism, safety profile and clinical use as a growth hormone secretagogue. BioDrugs, 1999 (Prakash A, Goa KL)
Safety
FDA status: Compounded medication, not FDA-approved.
Side effects and precautions
- Sermorelin is generally well tolerated.
- With troches, common, mild effects include a tingling or altered taste while it dissolves, headache, flushing, dizziness or sleepiness that pass in hours.
- Sermorelin is not for people with an active cancer, and your clinician needs to know about diabetes, thyroid disease, pregnancy or breastfeeding, and every medication you take, including steroids and thyroid hormone.
Get care right away
- Stop and seek care for hives, swelling of the face or lips or trouble breathing.
Questions
How is Sermorelin different from HGH?
HGH replaces the hormone directly and can suppress your own production. Sermorelin does the opposite: it signals your pituitary to release its own growth hormone in natural pulses, so levels rise gradually and stay within a physiological range.
How do troches work?
A small troche dissolves under the tongue, usually at night before bed, when your body naturally releases growth hormone. It absorbs through the lining of the mouth, so there is no injection. Your clinician sets the dose and schedule.
What are the side effects?
Most people tolerate it well. The most common effects are mild and short-lived: a tingling or altered taste while the troche dissolves, headache, flushing or sleepiness. Stop and seek care for hives, swelling or trouble breathing.
Is Sermorelin safe for long-term use?
Because sermorelin supports your own production rather than replacing the hormone, it is used as a maintenance plan. Your clinician reviews how you feel and, when appropriate, lab work at each check-in and decides with you whether to continue, adjust or pause.
Ready to start with Sermorelin Troches?
$279/mo · $279 billed every month
- Free shipping on every order
- No membership fee
- Same price at every dose
- HSA and FSA accepted
